date:Jan 22, 2014
Bioactor and Ferrerhealthtechhave announced the signature of a Collaboration Agreement to jointly develop and marketBioactors innovative cardiovascular ingredient cordiart in the Americas. Under this Agreement, parties will collaborate on additional clinical validation ofcordiartand pool resources to market and sellcordiartin the Americas.
Thanks to its proprietary process technology Ferrer HealthTech will custom-manufacture and exclusively supply cordiart toBioactor.
Cordiart, a specific ruti